Savara (SVRA) Debt to Equity (2015 - 2026)

Savara (SVRA) reported Debt to Equity of $0.17 for Q1 2026, down 14.47% year-over-year from $0.2 in Q1 2025, and up 16.01% quarter-over-quarter from $0.15 in Q4 2025.

Savara (SVRA) Debt to Equity (2015 - 2026) Analysis & Trends

Savara (SVRA) has 12 years of Debt to Equity data on file, last reported at $0.17 in Q1 2026.

  • Debt to Equity for Q1 2026 came in at $0.17, down 14.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.17 (down 14.47% YoY), and the FY2025 annual result was $0.15, down 5.17% from the prior year.
  • Debt to Equity grew to $0.17 in Q1 2026 per SVRA's latest filing, from $0.15 in the prior quarter.
  • Over five years, Debt to Equity peaked at $0.3 in Q2 2023 and troughed at -$192.14 in Q3 2025.
  • A 5-year average of -$19.39 and a median of $0.19 in 2022 frame the typical range for Debt to Equity.
  • The sharpest annual moves came in 2024 and 2025: Debt to Equity soared 100.16% in 2024, then plunged 144352.85% in 2025.
  • A 5-year view of Debt to Equity shows it stood at -$43.1 in 2022, then sank by 125.56% to -$97.23 in 2023, then soared by 100.16% to $0.16 in 2024, then slipped by 5.17% to $0.15 in 2025, then gained by 16.01% to $0.17 in 2026.
  • Business Quant data shows SVRA's Debt to Equity at $0.17 in Q1 2026, $0.15 in Q4 2025, and -$192.14 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 0.32
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn -
9 Abivax 90.15 Bn 90.15 Bn - -
10 Savara 1.33 Bn 1.33 Bn - 0.17

Historic Data

Download Data
DateValue
Mar 31, 2026 0.17
Dec 31, 2025 0.15
Sep 30, 2025 -192.14
Jun 30, 2025 0.25
Mar 31, 2025 0.20
Dec 31, 2024 0.16
Sep 30, 2024 0.13
Jun 30, 2024 0.26
Mar 31, 2024 0.22
Dec 31, 2023 -97.23
Sep 30, 2023 0.18
Jun 30, 2023 0.30
Mar 31, 2023 0.27
Dec 31, 2022 -43.10
Sep 30, 2022 0.22
Jun 30, 2022 0.20
Mar 31, 2022 0.19
Dec 31, 2021 0.18
Sep 30, 2021 0.16
Jun 30, 2021 0.15